News for Healthier Living
Early MS treatments differ most in relapses and MRI lesions, not disability
For people recently diagnosed with multiple sclerosis (MS), early treatment choices were associated with only slight differences after two years, based on the first treatment they used, according to a study published September 9, 2026, in Neurology(r) Open Access, an official journal of the American Academy of Neurology. The study found that B-cell-depleting therapies, which are given through an infusion in a vein and lower the number of B cells, a type of immune cell that can play a role in MS, were associated with lower relapse rates and reduced MRI lesion volume compared with oral therapies. While some treatments were associated with fewer relapses and MRI changes, researchers found no differences in disability scores after two years. The study does not prove that one treatment strategy causes better outcomes than another; it only shows associations.
September 9, 2026
September 10 2026September 9 2026 - How AI Is Changing Construction From Classroom to Job Site
- UTHealth Houston Team Reverses Nerve Pain in Diabetic Mice
- Keeping Elite Women's Basketball Players Healthy During International Competition
- New Interactive Map Helps States Navigate Wildfire-Energy Policy Activity
- 'Power Naps' May Improve Clinical Performance for Sleep-Deprived Anesthesiology Residents
- RNA Creates a Self-Destruct Switch for Cellular Machinery Linked to Leukemia
- New Tools Predict Which Tumors Will Respond to Treatment by Comparing Their Internal "Floor Plans"
- ASTRO to Showcase Advances in Radiation Medicine and Cancer Research in 2026 Annual Meeting Press Program
- Early MS treatments differ most in relapses and MRI lesions, not disability
- Cardiologists Expected This New Drug To Prevent Heart Attacks — So Why Did It Fail?
- Suicide-Related ER Visits In Children Rise, But Many Hospitals Lack Specialized Mental Health Care
- Semaglutide Linked To 40% Fewer Asthma Attacks
- Lied Center Celebrates Milestone in Expansion, Renovation
- Ribbon Cutting to Mark Mesonet Progress, Salute Stakeholders
- Virginia Tech Researchers Seek to Reduce Chronic Pain for Rural Adults
- Mayo Clinic Researchers Find a Way to Reprogram Immune Cells and Boost Chemotherapy Response in Glioblastoma
- A Road Paved by Research: A Johns Hopkins Medicine Patient's Experience with the Evolution of Sickle Cell Treatment
- Current Blood Pressure Thresholds May Miss Critically Injured Children
- Beyond the Prescription: How GLP-1 Companion Digital Programs Address Persistence to Medication and Postcessation Weight Regain
- Fake Doctor Reviews Look More Trustworthy Than Real Ones, Study Finds
- Psychedelics and Anesthetics Create Mirror Image Patterns in the Brain
- Pig Kidney Kept Man Alive For A Year While Awaiting A Human Organ Donation
- Students Hungry, Anxious, Distracted After End Of Universal Free School Meal Policy, Study Says
- The Market Forces Quietly Adding Thousands To Patient Bills
- Study Finds Social, Financial, and Healthcare Factors Shape Resilience in Adults with Sickle Cell Disease
- Gut, Airway and Tumor Microbes Emerge as Promising Predictors of Immunotherapy Response in Lung Cancer
- Spinal Cord Stimulation Eases Pain and Improves Sensation in People with Diabetic Nerve Damage
- Healthy lifestyle in middle age adds happiness alongside longevity to old age
- Vitamin A Metabolite Preserves T Cells' Function as KAIST Points to a New Strategy for Treating Intractable Brain Tumors
- Surgery-Centered Framework Reshapes Hepatocellular Carcinoma Care
- Alzheimer's: a Nasal Spray Protects Neurons and Memory
September 8 2026September 7 2026September 5 2026September 4 2026September 3 2026September 2 2026September 1 2026August 31 2026August 30 2026August 29 2026August 28 2026August 27 2026
|
|
|
|
|